Skip to main content

Table 3 Comparison between LR-TR Therapy response and mRECIST APHE in the first follow-up

From: Can triphasic hepatic multislice CT validate the LI-RADS treatment response algorithm after trans-catheter arterial chemoembolization treatment of hepatocellular carcinoma?

Statistic

Therapy response (Follow-up 1)

Equivocal with viable (%)

Therapy response (Follow-up 1)

Equivocal with nonviable (%)

mRECIST APHE (%)

Sensitivity

92.31

84.62

84.62

Specificity

83.33

100.00

75.00

Accuracy

88.00

92.00

80.00